In reply
Int J Tuberc Lung Dis
.
2015 Mar;19(3):367-8.
doi: 10.5588/ijtld.14.0852-2.
Authors
Sally Hoger
1
,
Kristine Lykens
1
,
Suzanne Beavers
2
,
Dolly Katz
2
,
Thaddeus Miller
3
Affiliations
1
<sup>*</sup>Tarleton State University, Fort Worth, TX.
2
<sup>‡</sup>Centers for Disease Prevention and Control, Atlanta, GA USA.
3
<sup>†</sup>University of North Texas Health Science Center<break/>Fort Worth, TX.
PMID:
25692934
DOI:
10.5588/ijtld.14.0852-2
No abstract available
Publication types
Letter
Comment
MeSH terms
Antitubercular Agents / therapeutic use*
Female
Humans
Latent Tuberculosis / mortality*
Longevity*
Male
Tuberculosis / mortality*
Substances
Antitubercular Agents